Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Trifluoperazine . dihydrochloride

ALX-550-310-G005 5 g 145.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: BML-CA310

Facilitates agonist induced elevation of cytosolic calcium at low concentrations (10µM). Antagonizes calmodulin at higher concentrations. Antipsychotic and sedative dopamine antagonist. Potent and irreversible inhibitor of cAMP-gated cationic channels. Inhibits DNA repair. Cell permeable. Potent neurotoxin.

Product Details

Formula:C21H24F3N3S . 2HCl
MW:407.5 . 73.0
MI:14: 9680
Purity:≥98% (UHPLC)
Identity:Identity determined by IR.
Appearance:White to off-white powder.
Solubility:Soluble in water (50mg/ml).
Shipping:Ambient Temperature
Long Term Storage:-20°C
Handling:Protect from light and moisture.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non small cell lung carcinoma cells to DNA double-strand break induced cell death: A.G. Polischouk, et al.; Mol. Cancer Ther. 6, 2303 (2007), Abstract;
Trifluoperazine protects brain plasma membrane Ca(2+)-ATPase from oxidative damaging: P. Souza dos Santos, et al.; Exp. Brain Res. 177, 347 (2007), Abstract;
Trifluoperazine stimulates ionizing radiation induced cell killing through inhibition of DNA repair: S. Gangopadhyay, et al.; Mutat. Res. 633, 117 (2007), Abstract;
Inhibition of Nav1.7 and Nav1.4 sodium channels by trifluoperazine involves the local anesthetic receptor: P.L. Sheets, et al.; J. Neurophysiol. 96, 1848 (2006), Abstract;
Inhibition of olfactory cyclic nucleotide-activated current by calmodulin antagonists: S.J. Kleene; Br. J. Pharmacol. 111, 469 (1994), Abstract;
Trifluoperazine-induced conformational change in Ca(2+)-calmodulin: M. Vandonselaar, et al.; Nat. Struct. Biol. 1, 795 (1994), Abstract;
Trifluoperazine binding to porcine brain calmodulin and skeletal muscle troponin C: J. Massom, et al.; Biochemistry 29, 671 (1990), Abstract;
Influence of calmodulin antagonist (stelazine) on agonist-induced calcium mobilization and platelet activation: G.H. Rao; BBRC 148, 768 (1987), Abstract;
New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme): H.L. Macfie, et al.; Drug Intel. Clin. Pharm. 15, 94 (1981), Abstract;

Related Literature

Download as PDF

All new literature pieces